Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Nasdaq has announced that Space Exploration Technologies Corporation (SpaceX) will be added to the Nasdaq-100 Index starting July 7, 2026. This inclusion signifies SpaceX's position among the largest Nasdaq-listed non-financial companies and exposes it to a broad range of investment products tracking the index, which collectively manage over $800 b…
Andrew Pardo Wright, a director at Slide Insurance Holdings, Inc. (NASDAQ: SLDE), has completed two separate transactions totaling $843,796 in common stock sales. Executed under a pre-arranged 10b5-1 trading plan, these divestitures took place on June 24 and June 26, 2026. The sales occurred while the company's stock demonstrated significant short-…
Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (NASDAQ: IMVT), executed a significant divestment of company equity on June 26, 2026. The transaction involved the sale of 40,000 shares, generating total proceeds of $1,532,309. This executive selling activity occurs against a backdrop of robust stock performance, with shares trading near …
Personalis, Inc. (NASDAQ: PSNL) Chief Executive Officer Christopher M. Hall executed a significant transaction involving the sale of company shares on June 26, 2026. The sale, valued at $1,315,000, was conducted under a Rule 10b5-1 trading plan established in late 2025. This financial activity occurred while the company's stock was trading near its…
Immunovant's Chief Operating Officer, Melanie Gloria, executed a significant sale of company shares in late June, reducing her direct holdings as the stock trades near its 52-week high. Despite the insider selling, the pharmaceutical company has garnered positive attention from multiple financial institutions citing robust clinical trial results an…
Dozens of fans who purchased World Cup tickets through ticket-resale platform StubHub say they were left without seats after last-minute cancellations and unfulfilled promises of replacement tickets. The incidents highlight speculative resale practices, platform delivery challenges tied to FIFA’s ticketing infrastructure, and growing public pressur…
Immunovant, Inc. (NASDAQ: IMVT) Chief Legal Officer Christopher Van Tuyl executed a significant stock sale on June 26, 2026, liquidating 17,824 shares for a total of $682,886. The transaction followed the exercise of stock options granted in April 2025 and occurred as the company's stock price approached its 52-week high of $39.28. This executive a…
Immunovant Inc. CFO Tiago Girao executed a significant stock sale on June 26, 2026, disposing of 10,000 shares for approximately $384,600. This divestment directly followed the exercise of stock options for the same volume of shares at a lower strike price. The transaction occurs against a backdrop of robust stock performance and positive clinical …
Brian C. Stephenson, Chief Financial Officer of Faeth Therapeutics, Inc. (NASDAQ:FTH), completed the acquisition of 15,641 shares valued at $401,268. The transactions were executed on June 24 and June 26, 2026, with purchase prices ranging from $23.61 to $27.77 per share. These purchases were made through the Brian Stephenson Revocable Trust, where…
Immunovant director Atul Pande sold 1,500 shares of company stock on June 26, 2026, valued at $57,015, pursuant to a Rule 10b5-1 trading plan adopted in December 2025. The sale coincides with Immunovant's stock trading near its 52-week high of $39.28, marking a significant 137% gain over the past year. Despite the company's unprofitable status, rec…
Omada Health CEO Sean P. Duffy sold 17,258 shares between June 24 and June 26, 2026, under a 10b5-1 plan adopted in March. The transaction occurred as the stock trades near $20.89, up 32% year-to-date, despite some valuation concerns. This follows Q1 2026 results showing a revenue jump of 42% to $78 million and an earnings surprise, alongside a pri…
UBS has raised its projection for the global security and safety market, forecasting growth to $974 billion in 2026 and to $1.19 trillion by 2029. The bank identifies cybersecurity as the primary driver of expansion, propelled by rising cyber threats, the adoption of generative AI, and regulatory tightening. Other segments such as testing and inspe…
Oak Valley Bancorp director Don Barton has executed a sale of 375 shares in the company, a transaction filed with the Securities and Exchange Commission that underscores routine corporate activity. The sale, conducted under a pre-arranged 10b5-1(c) plan, comes as the regional bank continues its long-standing practice of dividend growth and recent s…
Nayaab Islam, President and Chief Product Officer of StubHub Holdings, Inc. (NASDAQ:STUB), executed a sale of 25,080 shares of the company's Class A Common Stock on June 26, 2026. The transaction, valued at approximately $302,141, was processed under a pre-arranged Rule 10b5-1 trading plan established on March 15, 2026. Following the sale, Islam re…
Brett P. Monia, Chief Executive Officer of IONIS PHARMACEUTICALS INC (NASDAQ:IONS), sold approximately $6,825,523 worth of the company’s common stock between June 24 and June 26, 2026. These sales were executed at prices ranging from $78.4128 to $80.59 per share, pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. The transactions c…
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Executive Vice President of Research Eric Swayze completed a significant stock transaction on June 25, 2026, selling 10,602 shares of common stock. The sale, valued at $839,491, was executed under a Rule 10b5-1 trading plan established in March 2026. This financial activity occurs as Ionis Pharmaceuticals ad…
Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (NASDAQ:OMDA), executed a series of stock sales totaling $55,145 over two days in late June 2026. The transactions, conducted under a 10b5-1 trading plan established in March, reduced his direct holdings to 166,359 shares. This activity follows a period of significant market movement for…
Craig Gracey, the Chief Accounting Officer at Omada Health, Inc., executed a sale of 2,083 shares of the company's common stock on June 24, 2026. The transaction, valued at $39,601, was conducted under a pre-established 10b5-1 trading plan. This event occurs against a backdrop of recent financial performance and analyst activity. Omada Health recen…
William McCamey, Chief Financial Officer of Atlanticus Holdings Corp (NASDAQ: ATLC), executed a series of share sales totaling approximately $1.0945 million on June 26, 2026. The transaction, comprising 10,000 shares sold at a weighted average price of $109.45, occurs as the company's stock trades near its 52-week high of $112.61. This divestment f…
Jeffrey A. Howard, President and CEO of Atlanticus Holdings Corp (NASDAQ:ATLC), executed a significant stock sale on June 26, 2026, divesting 10,000 shares worth $1,094,500. The transaction, priced between $107.87 and $110.98 with a weighted average of $109.45 per share, leaves Howard with a direct holding of 673,265 shares. This move coincides wit…
Thrivent Financial for Lutherans, a significant 10% shareholder in Gloo Holdings Inc., executed a series of stock sales totaling $91,581 in value across three distinct transactions last week. The divestment involved the transfer of 21,000 Class A Common Stock shares at varying price points between $4.21 and $4.5434. This institutional selling occur…
MediaAlpha Inc. (NASDAQ: MAX) Chief Technology Officer Amy Yeh Kuanling completed a transaction involving the sale of 3,000 shares of the company's Class A Common Stock on June 26, 2026. Executed at $11.16 per share, the transaction totaled $33,480 and was facilitated through a Rule 10b5-1 trading plan initially established to satisfy tax obligatio…
XMax Inc. announced it has signed multiple AI API service contracts worth up to approximately $25 million, highlighting strong commercial adoption of its AI platform. Additionally, the company has entered the GPU-as-a-Service market, offering dedicated GPU computing resources to enterprise customers, integrating AI model API services with GPU infra…
A cluster of investment vehicles and individuals linked to Kymera Therapeutics, Inc. (NASDAQ: KYMR) executed a substantial divestment of common equity, totaling approximately $173.7 million on June 26, 2026. The transaction involved the sale of 1,630,658 shares at a uniform price of $106.50 per share. Despite this significant reduction in holdings,…
Vaxcyte Inc. Chief Executive Officer Grant Pickering executed a series of stock sales totaling $1,338,269 on June 26, 2026. The transactions were conducted under a Rule 10b5-1 trading plan established earlier in the year. The sale occurs as Vaxcyte shares have risen 72% over the past twelve months, with the stock price settling at $56.52 following …
